Raymond James Upgrades Hospira (HSP) to Market Perform
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James upgraded Hospira (NYSE: HSP) from Underperform to Market Perform.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $56.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight
- Desjardins Upgrades PRO REIT (PRV-U:CN) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
